Inovio Pharma Stock
Inovio Pharma Stock
With 6 Sell predictions and only 1 Buy predictions the community sentiment for Inovio Pharma is rather negative.
However, we have a potential of 463.91% for Inovio Pharma as the target price of 3 € is above the current price of 0.53 €.
For the coming years our community has positive and negative things to say abot the Inovio Pharma stock. Criterium "Business model" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.
Pros and Cons of Inovio Pharma in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Inovio Pharma vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Inovio Pharma | - | - | - | - | - | - | - |
| Ardelyx Inc. | 28.120% | 34.723% | 18.969% | 89.624% | 39.758% | 44.250% | - |
| Evolus Inc | 10.280% | 12.381% | -5.600% | 60.544% | 30.387% | 60.544% | - |
| Salarius Pharmaceuticals Inc. | 11.650% | 7.981% | 17.949% | -67.606% | -17.117% | -98.248% | -99.993% |
Comments
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Show more
Ratings data for INO provided by MarketBeat
Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for INO provided by MarketBeat